Moleculin Biotech, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $17.1M | $7.7M |
| FY2018 | — | $14.3M | $7.1M |
| FY2019 | — | $15.6M | $10.7M |
| FY2020 | — | $17.8M | $15.2M |
| FY2021 | — | $79.0M | $70.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $17.1M | $7.7M |
| FY2018 | — | $14.3M | $7.1M |
| FY2019 | — | $15.6M | $10.7M |
| FY2020 | — | $17.8M | $15.2M |
| FY2021 | — | $79.0M | $70.9M |